- Markets
- Healthcare
- NGLFINE
NGLFINE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
India's NGL Fine Chem back at 20-month low as profit slump negates pre-results rally
** India's NGL Fine Chem NGLF.NS slumps an exchange-allowed maximum of 20% back to 20-month low of 1,509.6 rupees
** Late Friday, NGLF reported Q3 profit from cont ops crashed 87%, mainly due to higher costs; rev inched up 1.3%
** Stock had also dropped 6% on Friday, ahead of results, which takes the 2-day tumble to 25%
** However, ahead of results, stock had run up ~27% in three-day rally, climbing off a 20-month low
** Taking the 3-day rally and 2-day slide into account, stock has overall lost 4.5% in past 5 sessions
** Trading volume has risen in this run, with latest day vol of 165k shares the highest and ~25x the 30-day daily moving avg
(Reporting by Hritam Mukherjee in Bengaluru)
(([email protected];))
** India's NGL Fine Chem NGLF.NS slumps an exchange-allowed maximum of 20% back to 20-month low of 1,509.6 rupees
** Late Friday, NGLF reported Q3 profit from cont ops crashed 87%, mainly due to higher costs; rev inched up 1.3%
** Stock had also dropped 6% on Friday, ahead of results, which takes the 2-day tumble to 25%
** However, ahead of results, stock had run up ~27% in three-day rally, climbing off a 20-month low
** Taking the 3-day rally and 2-day slide into account, stock has overall lost 4.5% in past 5 sessions
** Trading volume has risen in this run, with latest day vol of 165k shares the highest and ~25x the 30-day daily moving avg
(Reporting by Hritam Mukherjee in Bengaluru)
(([email protected];))
Ngl Fine Chem Says SEBI Issues Demand Notice In Settlement Proceedings
Jan 29 (Reuters) - Ngl Fine Chem Ltd NGLF.NS:
SEBI ISSUES DEMAND NOTICE IN SETTLEMENT PROCEEDINGS
SEBI IMPOSES PENALTY OF 5.4 MILLION RUPEES
Source text: ID:nBSEQhYqc
Further company coverage: NGLF.NS
(([email protected];;))
Jan 29 (Reuters) - Ngl Fine Chem Ltd NGLF.NS:
SEBI ISSUES DEMAND NOTICE IN SETTLEMENT PROCEEDINGS
SEBI IMPOSES PENALTY OF 5.4 MILLION RUPEES
Source text: ID:nBSEQhYqc
Further company coverage: NGLF.NS
(([email protected];;))
NGL Fine Chem Gets Suitability Certificate From Europe Regulator For Flunixin Meglumine
Aug 19 (Reuters) - NGL Fine Chem Ltd NGLF.NS:
GETS SUITABILITY CERTIFICATE FROM EUROPE REGULATOR FOR FLUNIXIN MEGLUMINE
Source text for Eikon: ID:nBSE7Dhmf2
Further company coverage: NGLF.NS
(Reporting by VijayDattaram Malkar)
(([email protected];))
Aug 19 (Reuters) - NGL Fine Chem Ltd NGLF.NS:
GETS SUITABILITY CERTIFICATE FROM EUROPE REGULATOR FOR FLUNIXIN MEGLUMINE
Source text for Eikon: ID:nBSE7Dhmf2
Further company coverage: NGLF.NS
(Reporting by VijayDattaram Malkar)
(([email protected];))
India's NGL Fine-Chem up 13% after Q4 profit jumps
** Shares of NGL Fine-Chem Ltd NGLF.NS rise as much as 13.05% to 1,743 rupees, hitting the highest level since Dec. 9
** Co on Monday reported 36% Y/Y jump in Q4 profit from continuing operations while revenue from ops fell 12.1%
** Pharma co also declared a final dividend of 1.75 rupees per shr
** Share price above 50-day, 100-day and 200-day simple moving averages, suggesting bullish trend
** NGLF's relative strength index above 70, indicating it is overbought
** More than 12,000 shares change hands by 9:39 a.m. IST, 2.8x 30-day avg of 4,335 shares
** Including session's gains, stock up ~11% YTD
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
** Shares of NGL Fine-Chem Ltd NGLF.NS rise as much as 13.05% to 1,743 rupees, hitting the highest level since Dec. 9
** Co on Monday reported 36% Y/Y jump in Q4 profit from continuing operations while revenue from ops fell 12.1%
** Pharma co also declared a final dividend of 1.75 rupees per shr
** Share price above 50-day, 100-day and 200-day simple moving averages, suggesting bullish trend
** NGLF's relative strength index above 70, indicating it is overbought
** More than 12,000 shares change hands by 9:39 a.m. IST, 2.8x 30-day avg of 4,335 shares
** Including session's gains, stock up ~11% YTD
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
India's NGL Fine Chem March-Quarter Consol Profit From Continuing Operations Rises
May 15 (Reuters) - Ngl Fine Chem Ltd NGLF.NS:
INDIA'S NGL FINE CHEM LTD MARCH-QUARTER CONSOL PROFIT FROM CONTINUING OPERATIONS 93.2 MILLION RUPEES VERSUS 68.7 MILLION RUPEES
NGL FINE CHEM LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 738.9 MILLION RUPEES VERSUS 840.6 MILLION RUPEES
DIVIDEND OF 1.75 RUPEES/SHR
Source text for Eikon: [ID:]
Further company coverage: NGLF.NS
(([email protected];))
May 15 (Reuters) - Ngl Fine Chem Ltd NGLF.NS:
INDIA'S NGL FINE CHEM LTD MARCH-QUARTER CONSOL PROFIT FROM CONTINUING OPERATIONS 93.2 MILLION RUPEES VERSUS 68.7 MILLION RUPEES
NGL FINE CHEM LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 738.9 MILLION RUPEES VERSUS 840.6 MILLION RUPEES
DIVIDEND OF 1.75 RUPEES/SHR
Source text for Eikon: [ID:]
Further company coverage: NGLF.NS
(([email protected];))
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does NGL Fine-Chem do?
NGL Fine-Chem Ltd specializes in manufacturing pharmaceuticals and intermediates for veterinary and human health, providing high-quality customizable solutions to global companies.
Who are the competitors of NGL Fine-Chem?
NGL Fine-Chem major competitors are Hikal, Sequent Scientific, Nectar Lifesciences, SMS Lifesciences, Kopran, Everest Organics, Shree Ganesh Remed.. Market Cap of NGL Fine-Chem is ₹674 Crs. While the median market cap of its peers are ₹963 Crs.
Is NGL Fine-Chem financially stable compared to its competitors?
NGL Fine-Chem seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does NGL Fine-Chem pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. NGL Fine-Chem latest dividend payout ratio is 2.63% and 3yr average dividend payout ratio is 3.36%
How has NGL Fine-Chem allocated its funds?
Companies resources are allocated to majorly unproductive assets like Accounts Receivable
How strong is NGL Fine-Chem balance sheet?
Balance sheet of NGL Fine-Chem is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of NGL Fine-Chem improving?
The profit is oscillating. The profit of NGL Fine-Chem is ₹32.63 Crs for TTM, ₹41.16 Crs for Mar 2024 and ₹20.41 Crs for Mar 2023.
Is the debt of NGL Fine-Chem increasing or decreasing?
Yes, The debt of NGL Fine-Chem is increasing. Latest debt of NGL Fine-Chem is ₹39.8 Crs as of Sep-24. This is greater than Mar-24 when it was ₹30.79 Crs.
Is NGL Fine-Chem stock expensive?
NGL Fine-Chem is not expensive. Latest PE of NGL Fine-Chem is 20.65, while 3 year average PE is 31.82. Also latest EV/EBITDA of NGL Fine-Chem is 17.07 while 3yr average is 24.01.
Has the share price of NGL Fine-Chem grown faster than its competition?
NGL Fine-Chem has given lower returns compared to its competitors. NGL Fine-Chem has grown at ~12.26% over the last 7yrs while peers have grown at a median rate of 15.92%
Is the promoter bullish about NGL Fine-Chem?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in NGL Fine-Chem is 72.74% and last quarter promoter holding is 72.74%.
Are mutual funds buying/selling NGL Fine-Chem?
There is Insufficient data to gauge this.